Technical Programme

February 6, 2020 (Thursday)


10:00 hrs


Welcome Address

Shri. Pankaj R. Patel
Chief Patron
The Ramanbhai Foundation, 9th International Symposium


10.10 hrs

Lighting of the lamp

10.15 hrs

Introduction to the keynote speaker
Sharvil P. Patel, Ph.D
Managing Director, Zydus Cadila

10.25 hrs

Inaugural Key Note Address
“Global Health R&D Priorities”

Marie-Paule Kieny, PhD
Chair of the Board, Drugs for Neglected Diseases Initiative (DNDi, Geneva, Switzerland)
Medicines Patent Pool Foundation (MPPF, Geneva, Switzerland)
Director of Research at INSERM, France
Vice-Chair of the Board of the Global Antibiotic Research and Development Partnership (GARDP, Geneva, Switzerland)
Member of the Board of Directors of the Human Vaccine Project (HVP, New York, USA)
Former Assistant Director-General for Health Systems and Innovation at the World Health Organization (WHO)

11.25 hrs

Vote of Thanks

Mr. Ganesh Nayak
COO & Executive Director, Zydus Cadila

11:30 hrs

Poster Session Inauguration

Sharvil P. Patel, Ph.D
Managing Director, Zydus Cadila

Tea Break

Session I : Infectious and Neglected Diseases

Chairpersons:

Suman Rijal, Ph.D
Mukul Jain, Ph.D

13:00 hrs

“Rationale Development of Novel Combination treatments against Malaria”

Joerg Mohrle, Ph.D
Vice President, Head of Translational Medicine,
Research & Development,
Medicines for Malaria Venture

13:30 hrs

“Development of Bedaquiline and new drug discovery challenges for infectious diseases”

Anil Koul, Ph.D
Vice-President and Head,
Global Public Health and Infectious Diseases  Discovery,    
Johnson & Johnson
Format Director, CSIR - IMTECH

14:00 hrs

Lunch

15:00 hrs

“Bolstering the TB Treatment Paradigm”

Shridhar Narayanan, Ph.D
Director
Foundation for Neglected Disease Research (FNDR)

15:30 hrs

“Development of a Cocktail mAbs product for passive immunization against Rabies”

Sanjeev Kumar, Ph.D
President
Zydus Biologics

16:00 hrs Tea-Break

16:30 hrs

ACS Five by Five session

  • Five early-career researchers (shortlisted by ACS based on their abstract)  will be allowed to present their research work on stage for five minutes using five slides.
  • ACS will award a specific journal certificate and a one year ACS membership to these shortlisted participants.

17:30 hrs

Wrap-up session


February 7, 2020 (Friday)

09:00 hrs

Key Note Address: “Year Gone By 2019 – Year Ahead 2020”

Naga Chalasani, MD, FACG
Associate Dean for Clinical Research and Director,
Division of Gastroenterology & Hepatology,
Indiana University School of Medicine

09:30 hrs

“Molecular Subclasses of NAFLD”

Arun Sanyal, MD
Professor of Medicine,
Physiology and   Molecular Pathology,
Virginia Commonwealth University

 

10:00 hrs

Tea-Break & Posters Session

Session II : Clinical/Risk factors/Natural History Aspects of NAFLD/NASH

Chairpersons:

Arun Sanyal, MD
Y. K. Chawla, MD

11:30 hrs

“Heterogenicity of NAFLD Patients”

Akash Shukla, MD, DM
Head of Department of Gastroenterology
King Edward Memorial Hospital, Mumbai

12:00 hrs

“NAFLD in LEAN Individuals”

Abhijit Chowdhury, MD, DNB, DM
Professor & Head, Department of Hepatology,
Institute of Post Graduate Medical Education & Research, Kolkata
Institute of Post Graduate Medical Education & Research     

12:30 hrs

“Sarcopenia & Frailty – Impact in NASH”

Kaushal Madan, MD, DNB, DM
Director of Gastroenterology & Hepatology Department,
Max Hospital, Gurgram
Max Hospital     

13:00 hrs

“Connection: CV & NASH”

Mohammad Siddiqui, MD
Associate Professor
Assistant Professor of Medicine
Department of Internal Medicine
Division of Gastroenterology, Hepatology and Nutrition Development,
Virginia Commonwealth University

13:30 hrs

Lunch  

Chairpersons: Naga Chalasani, MD, FACG
Alok Dhavan, Ph.D

14:30 hrs

“STATE of ART: Placebo Response Considerations in NASH Clinical trials”

Mazer Noureddin, MD, MHSc
Director
Cedars-Sinai Fatty Liver Program

15:00 hrs

“Innovations In Clinical Trial Designs in NASH”

Arun Sanyal, MD
Professor of Medicine,
Physiology and   Molecular Pathology,
Virginia Commonwealth University

15:30 hrs

“DILI in NAFLD”

Harshad Devarbhavi, MD, DM

Professor of Gastroenterology,
St. John's Medical College and Hospital, Bengaluru

16:00 hrs

Tea Break

16:30 hrs

PANEL DISCUSSION: 

How Should I (Gastro/ Endo views) treat NAFLD/NASH in my clinic?
 
Moderator: Ajay Duseja
KT Shenoy, Krishnadas D, Banshi Saboo, Ketan Mehta

17:15 hrs – 18.00 hours

PANEL DISCUSSION:  

Role of Social MEDIA in NASH AWARENESS

Moderator: Deven Parmar (Zydus Cadila)
Arun Sanyal, Naim Alkouri, Ketan Mehta, Ajay Duseja


February 8, 2020 (Saturday)

Chairpersons:

Narayanswamy, MD

09.00 hrs

Key Note Address: “Genetic Modifiers of NAFLD & NASH”

Naga Chalasani, MD, FACG
Associate Dean for Clinical Research and Director,
Division of Gastroenterology & Hepatology,
Indiana University School of Medicine

09:30 hrs

Key Note Address: “Fecal Microbial Transplant: Challenges & Opportunities”

Dr. Shiv Sarin, MD, DM
Senior Professor and Head, Department of Hepatology Director,
Institute of Liver and Biliary Science (ILBS)

Session III : Diagnostics

Chairpersons:

V. A. Saraswat, MD
Krishnadas, MD
Asita De Silva, MD

10:00 hrs

“STATE OF ART: Current Non Invasive Diagnostic Modalities? Which is Best?”

Raj Vuppalanchi, MD

Associate Professor of Medicine,
Indiana University School of Medicine

10:30 hrs

“Role of Metabolomics in NASH Development”

Pablo Ortiz, MD, PhD

Chief Executive Officer,
OWL Metabolomics

11:00 hrs

“Qualification of noninvasive tests for routine use in the clinic for NASH”

Arun Sanyal, MD
Professor of Medicine,
Physiology and   Molecular Pathology,
Virginia Commonwealth University

11:20 hrs

Tea-Break

Session IV: Advances in Pharmacotherapy - NASH

Chairpersons:

Abraham Koshy, MD
Sanjay Maroo, MD

12:00 hrs

“PPAR Biology & Novel applications for NASH”

Ajay Duseja, MD, DM
Department of Hepatology,
PGIMER, Chandigarh

12:20 hrs

“Skeletal Muscle - an overlooked link in the effective treatment for NAFLD/NASH”

Manu Chakravarthy, MD, PhD
Chief Medical Officer and Senior Vice President,
Clinical Development,
Axcella Health.

12:40 hrs

“STATE of ART: Strategies For NASH Drug Development – Key takeaways”

Arun Sanyal, MD
Professor of Medicine,
Physiology and   Molecular Pathology,
Virginia Commonwealth University

13:00 hrs

Lunch

Session V: Tropic of Special Interest

Chairpersons:

Sanjiv Saigal, MD
Ajay Duseja, MD
Nilay Mehta, MD

14:00 hrs

“STATE of ART: Implications of NASH cirrhosis on post LT clinical care”

Mohammad Siddiqui, MD
Associate Professor
Assistant Professor of Medicine
Department of Internal Medicine
Division of Gastroenterology, Hepatology and Nutrition Development,
Virginia Commonwealth University

14:40 hrs

“Paediatric NASH”

Naim Alkhouri, MD
Director of the Metabolic Health Center
Department of Internal Medicine
Texas Liver Institute, San Antonio

15:00 hrs

“Bariatric Surgery & NASH”

Raj Vuppalanchi, MD
Associate Professor of Medicine,
Indiana University School of Medicine

15:20 hrs

ACS : Five by Five

  • Five early-career researchers (shortlisted by ACS based on their poster
    presentation) will be allowed to present on stage for five minutes using five
    slides.

  • ACS will award a specific journal certificate and a one-year ACS membership to
    these shortlisted participants.

16:00 hrs

Vote of Thanks
Sharvil P. Patel, Ph.D
Managing Director, Zydus Cadila

16:10 hrs Tea

 


 

 
Home Contact Us Life-sciences Exhibition